Constant Therapy, Burke Rehab Partner For Outpatient Speech, Cognitive Therapy

Constant Therapy, a digital health company specializing in speech-language therapy, is partnering with Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients recovering from stroke, brain injuries, and other neurological conditions. The program combines Burke’s one-on-one outpatient rehabilitation with Constant Therapy’s digital platform, which uses advanced AI to deliver 24/7 personalized speech, language, and cognitive therapies. Patients will also receive three months of free, unlimited access to the Constant Therapy mobile app to continue their therapy between clinical visits.

This collaboration builds on a pilot within Burke’s intensive aphasia program, where patients using Constant Therapy alongside traditional rehabilitation achieved significant gains — over half improved more than 5.03 points on the Western Aphasia Battery-Revised (WAB-R), with an average increase of 8.9 points. The WAB-R assesses linguistic and non-linguistic skills to support differential diagnoses. Participants in the pilot included individuals recovering from stroke and traumatic brain injury.

Veera Anantha, Constant Therapy’s cofounder and CEO, called the partnership a milestone: “By integrating our AI technology, Burke is setting a new standard in speech therapy and cognitive rehabilitation unmatched in New York.”

Earlier this year, Constant Therapy expanded its offerings by adding Spanish and Indian English language editions, enabling more culturally and linguistically tailored exercises for people with neurological conditions such as stroke, aphasia, dementia, and apraxia. The broader speech therapy space has also seen activity from companies like Expressable, which raised $26M in 2024 to grow its virtual care platform for children and adults with speech and language disorders, and Great Speech, which in 2023 became an in-network provider for TRICARE West, expanding its virtual therapy services for military families, Medicare members, and others with conditions such as Parkinson’s, aphasia, and brain injury.